Artemedica will soon offer JUVÉDERM VOLLURE® XC (also known as Juvederm Volift in Europe). Allergan (makers of Botox, JUVÉDERM , JUVÉDERM VOLUMA and JUVÉDERM VOLBELLA) are expected to add the newest filler to their expanding U.S. aesthetic profile this Spring. It is in its final stages of FDA Approval.
When JUVÉDERM VOLLURE is approved by the FDA, Artemedica will be one of the first practices in the United States to offer it. Dr. Victor Lacombe, Allergan National Trainer & Top 100 Provider, will be using this filler to smooth deep wrinkles for a refreshed look, as well as gently restoring natural-looking contours in the lower face. JUVÉDERM VOLLURE will last up to 18 months!
Stay tuned for more information!